NATCOPHARM
Natco Pharma Limited
Pharmaceuticals · ₹17,221 Cr market cap
A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.
2
Tracked investors holding
2
Tracked moves
₹962
Share price
Latest activity
Recent moveDecreased
SATYA VANI NANNAPANENI of the promoter group sold 45,000 shares of Natco Pharma for ₹4.51 Cr at ₹1001.33 apiece in a market sale, decreasing her stake from 0.21% to 0.19%.
Top investors holding Natco Pharma Limited
2.31%
1.01%